Nicotine free cigarettes is one of 262 small molecule programs targeting Joint Replacement Surgery. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
206 competitors in Lung Cancer
Keytruda
Imfinzi
Tagrisso
Yervoy
Imjudo
Tecentriq
Alunbrig
Alecensa
Ilaris
Verzenio
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources